• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Off-Label Drugs: Initial Results of a National Survey: PEMD-91-12BR

Off-Label Drugs: Initial Results of a National Survey: PEMD-91-12BR

Paperback

General Political Science

ISBN10: 1289057397
ISBN13: 9781289057398
Publisher: Bibliogov
Published: Jun 27 2013
Pages: 36
Weight: 0.18
Height: 0.07 Width: 7.44 Depth: 9.69
Language: English
Pursuant to a congressional request, GAO provided information about its survey of a nationally representative sample of oncologists to determine the extent to which health insurers denied patients reimbursement for off-label drug use, focusing on: (1) the prevalence of off-label drug use, and how its use varied by clinical, demographic, and geographic factors; (2) the extent to which third-party payers denied payment for such use; and (3) whether third-party payers' policies influenced the treatment of cancer patients.

GAO presented a copy of the questionnaire it mailed to the random sample of oncologists, with the number or percentage of respondents answering each item. GAO noted that it received a 56-percent response rate to its mailing of 1,470 questionnaires.

Also in

General Political Science